Navigation Links
Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter
Date:9/3/2008

e being held in Anaheim, California, September 23 -- 26, 2008.

Artelis and Selexis plan to expand the testing of the combined technologies by evaluating the iCELLis(TM) platform with Selexis generated HEK293 cells lines.

About the Artelis iCELLis(TM) Technology:

iCELLis (TM) is a proprietary, single-use, technology developed by Artelis. iCELLis(TM) is designed to achieve and maintain high-cell densities on macrocarriers in a fixed-bed system. Achieving high-cell densities allows compact iCELLis(TM) bioreactors to equal the productivity of much larger stirred-tank units. Depending on cell type and process, iCELLis(TM) can achieve 20-100x the volumetric productivity of a stirred-tank bioreactor.

iCELLis(TM) represents the next generation of disposable bioreactor technology, enabling process intensification in upstream processing by reducing bioreactor scale and simplifying operations.

About Artelis:

Artelis is an international and innovative SME founded in 2005. Capitalised by an American company listed on NASDAQ, Artelis is the privileged partner of world-leading pharmaceutical groups. The company has broad experience with disposable technologies: Artelis developed the Newmix(R) Jet Drive(TM), disposable mixing system, and co-developed the Nucleo(TM) disposable bioreactor together with ATMI Lifesciences and Pierre Guerin Biolafitte. Artelis is concerned by the process intensification needs in the biotech industry and dedicated to process development in disposable technologies. Artelis' mission is to create the future means of producing proteins, cells and viruses for key markets: monoclonal antibodies, cell therapy, vaccines and gene therapy. For more information, please visit http://www.artelis.be.

About the Selexis Genetic Elements(TM):

Selexis Genetic Elements (TM) are applied to control the dynamic organization of transgenes in the chromatin of eukaryotic pro
'/>"/>

SOURCE Selexis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma
2. Previous Claims of siRNA Therapeutic Effects Called into Question by Report in Human Gene Therapy
3. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
4. Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin
5. Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
6. Cardium Reports on Second Quarter 2008 Highlights and Financial Results
7. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
8. Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
9. Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
10. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
11. New AVAC Report on Pre-Exposure Prophylaxis Calls for Immediate Planning to Anticipate Study Results of Potential New HIV Prevention Option
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 2015  Xencor, Inc. (NASDAQ: XNCR ), a ... treatment of autoimmune diseases, asthma and allergic diseases, and ... financial results after the market closes on Tuesday, August ... conference call the same day at 4:30 p.m. ET ... provide a corporate update. The live call ...
(Date:7/28/2015)...  Champions Oncology, Inc. (OTC: CSBR), engaged in the ... the development and use of oncology drugs, today announced ... 2015. Fourth Quarter and Recent Business Highlights: ... prior year period result , Procured a quarterly ... Joel Ackerman, Champions Oncology CEO, stated, "The end of ...
(Date:7/28/2015)... July 28, 2015  Cepheid (Nasdaq: CPHD ... and portable clinical molecular diagnostic system designed to ... market.  At just 9 inches tall, and weighing ... the same high quality PCR-based Xpert® cartridges as ... accurate clinical molecular diagnostic tests to be performed ...
Breaking Medicine Technology:Xencor to Host Second Quarter 2015 Financial Results Webcast and Conference Call on August 4, 2015 2Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 2Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 3Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 4Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 5Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 6Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 7Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 8Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 9Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 10Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 11World's First "Go-Anywhere" Molecular Diagnostic System Unveiled at AACC 2World's First "Go-Anywhere" Molecular Diagnostic System Unveiled at AACC 3World's First "Go-Anywhere" Molecular Diagnostic System Unveiled at AACC 4
... Expand Testing Using Cellular ... Antioxidant Activity Assay, ... with the release of results from a new study,showing Wild ... red grapes and strawberries in an expanded,test using the Cellular ...
... Oct. 8 Vical Incorporated (Nasdaq: VICL ... nonclinical data,demonstrating that the company,s Vaxfectin(R) adjuvant may ... vaccines and,peptide-based cancer vaccines. Alain P. Rolland, Pharm.D., ... present the data today,Wednesday, October 8, at the ...
Cached Medicine Technology:Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5
(Date:7/28/2015)... ... July 28, 2015 , ... ADLINK Technology, a leading ... devices that enable the Internet of Things (IoT), announced its new medical panel ... provide exceptional computing power and multitasking capabilities. The MLC 4-21 is completely fanless, ...
(Date:7/28/2015)... ... July 28, 2015 , ... OrthAlign, Inc., ... its ORTHALIGN PLUS® system, a palm-sized, single-use navigation device for Total Hip Arthroplasty ... precision with practicality in a revolutionary way for Total Knee Arthroplasty surgeries and ...
(Date:7/28/2015)... ... July 28, 2015 , ... On July 16th ... to schedule the hearing of proposed bills and laws revolving the implementation of a ... to date. Some vigilante ministers are continuing to hand out clean needles to drug ...
(Date:7/28/2015)... ... July 28, 2015 , ... BiologicsMD, Inc. , a ... the treatment of bone disorders and conditions of hair loss, announced that the ... of Collagen Binding-Domain and Parathyroid Hormone". The issued patent claims methods of use ...
(Date:7/28/2015)... ... ... Fertility specialist Dr. Lisa Hasty of Atlanta Center for Reproductive ... Atlanta Magazine's annual Top Doctors issue, Dr. Hasty has been recognized for the fifth ... metro area as one of the most respected doctors in Reproductive Endocrinology. , “I’m ...
Breaking Medicine News(10 mins):Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 2Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 3Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 3Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 2Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 3Health News:BiologicsMD, Inc. Announces Additional US Patent Issuance Covering Company’s Pipeline of Targeted Therapies 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 2Health News:Atlanta Fertility Specialist Named Top Doctor in Atlanta Magazine 3
... shorts in football prints and innerwear with net inserts ... lingerie designers are experimenting with.,Overall, the trend in lingerie ... with a hint of romance. The seductive undergarments require ... being tried with embroidery. The garments aren't so opulent, ...
... 7,000 cancer tumour samples for researchers all over the world ... the world over are hailing this step as a major ... truly international. ,"Cancer is not just one disease, ... misbehaving. Since it is multiple diseases, you have to have ...
... death has been reported in Egypt, the most populous North ... woman //, indeed died as a consequence of the highly ... from Nawa village in Qalyubiya, some 40 km north of ... she had been treated for flu-like symptoms, the health ministry ...
... the avian influenza H5N1 virus is receiving samples from across ... arrive each week, packed in ice boxes. // These samples ... chicken deaths and from routine surveillance sites. , ... Animal Disease Laboratory in Bhopal, is running out of space ...
... in kidney transplant recipients can be used in treatment ... 40 years ago, is still used to prevent the ... ,In around the 1960s, Roy Calne showed that ... this finding, a combination of azathioprine and corticosteroids were ...
... the direction of development of prosthetic limbs researchers at University ... by alcohol and hydrogen. // ,As it appears ... than the body's own. ,Two types of ... Institute at the University of Texas in Dallas, working with ...
Cached Medicine News:Health News:Romantic and discreet trends in lingerie 2Health News:Azathioprine Can Soon Revolutionize Eczema Treatment 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: